Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial-Reference-Cited by-同舟云学术

Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial

Published:2018-05-24 Issue:8 Volume:46 Page:888-894
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin. Experiment. Ophthalmol.

Author:

Sherwin Justin C¹²³^ORCID,Ratnarajan Gokulan⁴,Elahi Babar⁵,Bilkiewicz‐Pawelec Anna¹,Salmon John F¹

Affiliation:

1. Oxford Eye Hospital, John Radcliffe Hospital Oxford UK

2. Ophthalmology, University of Melbourne Department of Surgery Melbourne Australia

3. Centre for Eye Research AustraliaRoyal Victorian Eye and Ear Hospital Melbourne Australia

4. The Queen Victoria Hospital East Grinstead UK

5. Dudley Hospital NHS Trust Dudley UK

Funder

University of Melbourne

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.13311

Reference29 articles.

1. National Institute for Health and Clinical Excellence. Glaucoma: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. Costing Report.2009;http://www.nice.org.uk/nicemedia/live/12145/44043/44043.pdf.

2. Preservatives in eyedrops: The good, the bad and the ugly

3. Ocular Surface Disease and Quality of Life in Patients With Glaucoma

4. Prevalence of and Risk Factors for Dry Eye Syndrome

5. Incidence and Prevalence of Glaucoma in Severe Ocular Surface Disease

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery Systems for Glaucoma: A Narrative Review;Pharmaceuticals;2024-09-02

2. Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs;Journal of Glaucoma;2023-07-21

3. Strategies for the Management of Ocular Surface Disease in Glaucoma;Canadian Eye Care Today;2023-02-01

4. Topical glaucoma medications – Clinical implications for the ocular surface;The Ocular Surface;2022-10

5. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations;AAPS PharmSciTech;2021-03-14